November 1, 2017November 1, 2017

Humanetics’ BIO 300 Shows Promise in Preventing Radiation-induced ED and Tumor Growth in Prostate Cancer

News

A recent study using animals demonstrated that Humanetics‘ BIO 300 reduces radiation-induced erectile dysfunction and slows tumor growth. Radiation-induced erectile dysfunction is a common side effect observed in more than ... Read more

January 27, 2017January 27, 2017

Humanetics’ Treatment for Erectile Dysfunction in Radiation-treated Patients, BIO 300, Given Patent

News

Humanetics Corporation has received a U.S. patent for its BIO 300 compound, which it developed to prevent erectile dysfunction in men receiving radiation therapy for prostate cancer. Two professors at ... Read more